NeuroMetrix (NURO)
NeuroMetrix Revenues: 2.082M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
NURO Revenues Rankings
| Overall | 3rd percentile | 4264 of 4432 |
| Sector | 16th percentile | 392 of 470 in Healthcare |
| Industry | 13th percentile | 58 of 67 in Medical Instruments & Supplies |
NURO Revenues Range, Past 5 Years
| Minimum | 2.082M | Mar 2012 |
| Maximum | 11.48M | Jun 2007 |
| Average | 5.777M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these NURO related companies
NURO News
NeuroMetrix Ships 500th Medical Device For Detecting Nerve Damage in Diabetics
May 24, 8:00AM Business Wire
May 24, 8:00AM Business Wire
NeuroMetrix CEO Discusses Significance of WellMed Adoption of NC-stat® DPNCheck™
May 17, 12:43PM Business Wire
May 17, 12:43PM Business Wire
NeuroMetrix to Showcase Test for Diabetic Neuropathy at International Meeting
May 09, 7:00AM Business Wire
May 09, 7:00AM Business Wire
NeuroMetrix, Inc. Announces Date for 2012 First Quarter Financial Results Conference Call
Apr 17, 7:00AM Business Wire
Apr 17, 7:00AM Business Wire
NeuroMetrix Initiative to Support American Diabetes Association Alert Day®
Mar 20, 7:00AM Business Wire
Mar 20, 7:00AM Business Wire
Medical Profits from Aging & Emerging Markets http://stks.co/x6c $PRGO $NURO $BSX $ABT $SYK
about 209 days ago by ZacksResearch
about 209 days ago by ZacksResearch
$NURO http://chart.ly/gws7839 NURO - 10 down days and off 18.87% in the last month - http://www.barchart.com/quotes/stocks/NURO
about 336 days ago by jimvanmeerten
about 336 days ago by jimvanmeerten
$nuro Deerfield Special Situations F sold 331,900 shrs @ $0.51 totl amnt $169,130.00 12/14/2010
about 533 days ago by canarionyc
about 533 days ago by canarionyc
in & out of $SYMX for a small profit. looking for an entry in to $NURO
about 988 days ago by Finchy789
about 988 days ago by Finchy789
In $NURO 2.80. Sold 1/2 $CNO for .59 profit. Will let the rest run for a while.
about 989 days ago by BarrieAbalard
about 989 days ago by BarrieAbalard
NASDAQ 3 biggest advancers: $CMRO 33.98%, $ASFN 32.66%, $NURO 30.04%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 990 days ago by datajunkies
about 990 days ago by datajunkies
NASDAQ 3 biggest advancers: $CMRO 33.98%, $ASFN 32.66%, $NURO 30.04%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 990 days ago by datajunkies
about 990 days ago by datajunkies
@johnwelshphd I'm thinking about buying the $2.5 Dec calls on $NURO & selling if closes below $2.83. Do you think it can run higher?
about 990 days ago by elwalvador
about 990 days ago by elwalvador
@R_agarwal That $NURO 501k news was a few days old. It has a bad, corrupt history too. They need approval code to get back on track.
about 992 days ago by johnwelshtrades
about 992 days ago by johnwelshtrades
We picked $NURO, NEUROMETRIX INC COM at a signal price of $3.03 today.
about 992 days ago by jimsnyder
about 992 days ago by jimsnyder
NASDAQ 3 biggest advancers: $CMRO 33.98%, $ASFN 32.66%, $NURO 30.04%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 992 days ago by datajunkies
about 992 days ago by datajunkies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NURO | 0.72 | -0.02 | -2.70% | 9.198M |
| NUO | 17.50 | +0.01 | +0.06% | |
| NUM | 15.41 | -0.01 | -0.06% | |
| NUE | 35.90 | -0.71 | -1.94% | 11.61B |
| NUCL | 31.31 | +0.16 | +0.52% | |
| NUAN | 20.77 | -0.63 | -2.94% | 6.595B |
| NU | 35.95 | -0.80 | -2.18% | 6.512B |
| NTZ | 2.78 | +0.09 | +3.35% | 151.62M |
| PFE | 22.04 | -0.14 | -0.63% | 167.18B |
| PFD | 13.85 | -0.04 | -0.29% |
